Skip to main content
SpringerLink
Log in

Resilience as Basis for Sustainability: Shortages in Production Supply Chains for Essential Consumer Goods

  • Chapter
  • First Online:
Innovative Solutions for Sustainable Supply Chains

Part of the book series: Understanding Complex Systems ((UCS))

Abstract

Some consumer products, termed essential consumer goods, are crucial to sustaining health or even life. A shortage in supply of essential consumer goods can have tangible negative impacts on society. This study applies this topic to the case of inexpensive, generic, injectable oncological medication shortages in Europe. Cancer patient outcomes including survival rates, as well as treatment costs, are significantly influenced by oncological medicines shortages. Even though the problem is well documented and universally acknowledged, a lack of data has deterred any quantitative solution-oriented studies. However, a structural model can provide reliable insight in cases where data is unavailable or unreliable through relying on structural validation.

This study proposes the first causal model showing the underlying structure of the European inexpensive, generic, injectable oncological medications supply chain. This study identifies the most common causes of supply shortages and develops a quantitative supply chain model with the ability to simulate causes of identified shortages. Finally, key performance indicators are proposed to evaluate the sustainability of the supply chains in question from several perspectives.

Our study calls for a quantitative comparison and robust sensitivity analysis of all primary and secondary causes of medicines shortages using the proposed model. Furthermore, both existing and new policy recommendations regarding oncological medicines shortages in Europe should be studied quantitatively.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Change history

  • 25 November 2018

    The sequence of the authors names was incorrect and it has now been corrected as Lize Duminy and Stefan N. Grosser.

Notes

  1. 1.

    Birgli (2013)‘s headings “economic” and “business” correspond to “economic” causes of medicines shortages in Pauwels et al. (2014), while Birgli (2013)‘s heading “manufacturing” corresponds to “production” causes of medicines shortages in Pauwels et al. (2014).

  2. 2.

    Due to the lack of data available, the total production sizes are estimated in the examples shown in this study.

References

  • Barlas, Y. (1989). Multiple tests for validation of system dynamics type of simulation models. European Journal of Operational Research, 42, 59–87.

    Article  Google Scholar 

  • Barlas, Y. (1990). An autocorrelation function test for out put validation. Simulation, 55, 7–16.

    Article  Google Scholar 

  • Barlas, Y. (1996). Formal aspects of model validity and validation in system dynamics. System Dynamics Review, 12, 183–210.

    Article  Google Scholar 

  • Becker, D. J., Talwar, S., Levy, B. P., Thorn, M., Roitman, J., Blum, R. H., Harrison, L. B., & Grossbard, M. L. (2013). Impact of oncology drug shortages on patient therapy: Unplanned treatment changes. Journal of Oncology Practice, 9, e122–e128.

    Article  Google Scholar 

  • Bhattacharjee, S., & Cruz, J. (2015). Economic sustainability of closed loop supply chains: A holistic model for decision and policy analysis. Decision Support Systems, 77, 67–86.

    Article  Google Scholar 

  • Birgli. (2013). An evaluation of medicines shortages in Europe with a more in-depth review of these in France, Greece, Poland, Spain, and the United Kingdom.

    Google Scholar 

  • Bogaert, P., Bochenek, T., Prokop, A., & Pilc, A. (2015). A qualitative approach to a better understanding of the problems underlying drug shortages, as viewed from Belgian, French and the European Union’s Perspectives. PLoS One, 10, e0125691.

    Article  Google Scholar 

  • Cherny, N., Sullivan, R., Torode, J., Saar, M., & Eniu, A. (2016). ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe. Annals of Oncology, 27, 1423–1443.

    Article  Google Scholar 

  • De Weerdt, E., Simoens, S., Casteels, M., & Huys, I. (2015). Toward a European definition for a drug shortage: A qualitative study. Frontiers in Pharmacology, 6, 253.

    Article  Google Scholar 

  • Disney, S. M., & Towill, D. R. (2003). The effect of vendor managed inventory (VMI) dynamics on the Bullwhip Effect in supply chains. International Journal of Production Economics, 85, 199–215.

    Article  Google Scholar 

  • Dubey, R., Gunasekaran, A., Childe, S. J., Papadopoulos, T., & Fosso Wamba, S. (2017). World class sustainable supply chain management: critical review and further research directions. International Journal of Logistics Management, 28, 332–362.

    Article  Google Scholar 

  • EAHP. (2014). Medicines Shortages in European Hospitals: The evidence and case for action. Brussels: European Association of Hospital Pharmacists (EAHP).

    Google Scholar 

  • Economist Intelligence Unit. (2017). Cancer medicines shortages in Europe: Policy recommendations to prevent and manage shortages. London: The Economist.

    Google Scholar 

  • Elkington, J. (1998). Cannibals with Forks: The triple bottom line of the 21st century. Stoney Creek: New Society Publishers.

    Google Scholar 

  • Elkington, J. (2004). Enter the triple bottom line. In A. Henriques & J. Richardson (Eds.), The triple bottom line: Does it all add up? London: Earthscan.

    Google Scholar 

  • EMA. (2012). Reflection paper on medicinal product supply shortages caused by manufacturing/Good Manufacturing Practice Compliance problems.

    Google Scholar 

  • EMA. (2016). Developing a proactive approach to the prevention of medicines shortages due to manufacturing and quality problems. London. http://www.ema.europa.eu/docs/en_GB/document_library/Report/2016/01/WC500200281.pdf

  • Forrester, J. W. (1958). Industrial dynamics-a major breakthrough for decision makers. Harvard Business Review, 36, 37.

    Google Scholar 

  • Forrester, J. W. (1961). Industrial dynamics. Cambridge, MA (now available from Pegasus Communications, Waltham, MA): MIT Press.

    Google Scholar 

  • Forrester, J. W. (1980). Information sources for modeling the national economy. Journal of the American Statistical Association, 75, 555–566.

    Article  Google Scholar 

  • Fox, E. R., Sweet, B. V., & Jensen, V. (2014). Drug shortages: A complex health care crisis. Mayo Clinic Proceedings. Elsevier, 361-373.

    Google Scholar 

  • Ganslandt, M., & Maskus, K. E. (2004). Parallel imports and the pricing of pharmaceutical products: Evidence from the European Union. Journal of Health Economics, 23, 1035–1057.

    Article  Google Scholar 

  • Georgiadis, P., & Athanasiou, E. (2013). Flexible long-term capacity planning in closed-loop supply chains with remanufacturing. European Journal of Operational Research, 225, 44–58.

    Article  Google Scholar 

  • Georgiadis, P., & Besiou, M. (2008). Sustainability in electrical and electronic equipment closed-loop supply chains: A system dynamics approach. Journal of Cleaner Production, 16, 1665–1678.

    Article  Google Scholar 

  • GIRP. (2013). Medicine shortages in Europe and their impact on patients: A reflection paper.

    Google Scholar 

  • Gogineni, K., Shuman, K. L., & Emanuel, E. J. (2013). Survey of oncologists about shortages of cancer drugs. New England Journal of Medicine, 369, 2463–2464.

    Article  Google Scholar 

  • Goldsack, J. C., Reilly, C., Bush, C., Mcelligott, S., Bristol, M. N., Motanya, U. N., Field, R., Vozniak, J. M., Wong, Y.-N., & Schwartz, J. S. (2014). Impact of shortages of injectable oncology drugs on patient care. American Journal of Health-System Pharmacy, 71, 571.

    Article  Google Scholar 

  • Groesser, S. N., & Schwaninger, M. (2012). Contributions to model validation: Hierarchy, process, and cessation. System Dynamics Review, 28, 157–181.

    Article  Google Scholar 

  • Harland, D. (1987). The United Nations guidelines for consumer protection. Journal of Consumer Policy, 10, 245–266.

    Article  Google Scholar 

  • Havrilesky, L. J., Garfield, C. F., Barnett, J. C., & Cohn, D. E. (2012). Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer. Gynecologic Oncology, 125, 631–634.

    Article  Google Scholar 

  • Hayes, M. S., Ward, M. A., Slabaugh, S. L., & Xu, Y. (2014). Lessons from the leucovorin shortages between 2009 and 2012 in a medicare advantage population: Where do we go from here? American health & drug benefits, 7, 264.

    Google Scholar 

  • Hedman, L. (2016). Global approaches to addressing shortages of essential medicines in health systems. WHO Drug Information, 30, 180.

    Google Scholar 

  • Hutchins, M. J., & Sutherland, J. W. (2008). An exploration of measures of social sustainability and their application to supply chain decisions. Journal of Cleaner Production, 16, 1688–1698.

    Article  Google Scholar 

  • Kamath, N. B., & Roy, R. (2007). Capacity augmentation of a supply chain for a short lifecycle product: A system dynamics framework. European Journal of Operational Research, 179, 334–351.

    Article  Google Scholar 

  • Kweder, S. L., & Dill, S. (2013). Drug shortages: The cycle of quantity and quality. Clinical Pharmacology & Therapeutics, 93, 245–251.

    Article  Google Scholar 

  • Lai, D., & Wahba, R. (2001). System dynamics model correctness checklist. MIT D-Memo, D-4851(1), 15.

    Google Scholar 

  • Lehr, C. B., Thun, J.-H., & Milling, P. M. (2013). From waste to value – a system dynamics model for strategic decision-making in closed-loop supply chains. International Journal of Production Research, 51, 4105–4116.

    Article  Google Scholar 

  • Lin, W.-J., Jiang, Z.-B., Liu, R., & Wang, L. (2014a). The bullwhip effect in hybrid supply chain. International Journal of Production Research, 52, 2062–2084.

    Article  Google Scholar 

  • Lin, W.-J., Jiang, Z.-B., & Wang, L. (2014b). Modelling and analysis of the bullwhip effect with customers’ baulking behaviours and production capacity constraint. International Journal of Production Research, 52, 4835–4852.

    Article  Google Scholar 

  • Martinelli, E. (2017). Interview about medicine shortages (not published, personal communication).

    Google Scholar 

  • Martinez-Moyano, I. J. (2012). Documentation for model transparency. System Dynamics Review, 28, 199–208.

    Article  Google Scholar 

  • Mehrjoo, M., & Pasek, Z. J. (2016). Risk assessment for the supply chain of fast fashion apparel industry: A system dynamics framework. International Journal of Production Research, 54, 28–48.

    Article  Google Scholar 

  • Pauwels, K., Huys, I., Casteels, M., & Simoens, S. (2014). Drug shortages in European countries: A trade-off between market attractiveness and cost containment? BMC Health Services Research, 14, 438.

    Article  Google Scholar 

  • Pauwels, K., Simoens, S., Casteels, M., & Huys, I. (2015). Insights into European drug shortages: A survey of hospital pharmacists. PLoS One, 10, e0119322.

    Article  Google Scholar 

  • Pruyt, E. (2013). Small system dynamics models for big issues: Triple jump towards real-World complexity. Delft: TU Delft Library.

    Google Scholar 

  • Rahmandad, H., & Sterman, J. D. (2012). Reporting guidelines for simulation-based research in social sciences. System Dynamics Review, 28, 396–411.

    Article  Google Scholar 

  • Richardson, G. P. (2000). Richardson’s rule. Simulating dynamic systems (PAD 624 Course) lecture notes. University at Albany, State University of New York.

    Google Scholar 

  • Richardson, G. P., & Pugh, A. I., III. (1981). Introduction to system dynamics modeling with DYNAMO. Productivity Press: Cambridge, MA.

    Google Scholar 

  • Rider, A. E., Templet, D. J., Daley, M. J., Shuman, C., & SMITH, L. V. (2013). Clinical dilemmas and a review of strategies to manage drug shortages. Journal of Pharmacy Practice, 26, 183–191.

    Article  Google Scholar 

  • Senge, P. M., & Forrester, J. W. (1980). Tests for building confidence in system dynamics models. In System dynamics, TIMS studies in management sciences (Vol. 14, pp. 209–228).

    Google Scholar 

  • Sterman, J. (2000). Business dynamics: Systems thinking and modeling for a complex world. Boston: Irwin/McGraw-Hill.

    Google Scholar 

  • System Dynamics Society. (2017). Tools for system dynamics: SDM-Doc [Online]. Available: http://tools.systemdynamics.org/sdm-doc/ Accessed 15 July 2017.

  • Van Boom, W., & Garde, A. (2016). The European unfair commercial practices directive: Impact, enforcement strategies and national legal systems. London: Routledge.

    Book  Google Scholar 

  • Vlachos, D., Georgiadis, P., & Iakovou, E. (2007). A system dynamics model for dynamic capacity planning of remanufacturing in closed-loop supply chains. Computers & Operations Research, 34, 367–394.

    Article  Google Scholar 

  • Wangphanich, P., Kara, S., & Kayis, B. (2010). Analysis of the bullwhip effect in multi-product, multi-stage supply chain systems-a simulation approach. International Journal of Production Research, 48, 4501–4517.

    Article  Google Scholar 

  • WHO. (2015). Executive Board 138th session: Addressing the global shortage of medicines, and the safety and accessibility of children’s mediciation. Geneva: World Health Organization.

    Google Scholar 

  • WHO. (2017). Technical definitions of shortages and stockouts of medicines and vaccines. Geneva: World Health Organization.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Engineering, Bern University of Applied Sciences, Biel, Switzerland

    Lize Duminy & Stefan N. Grosser

Authors
  1. Lize Duminy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefan N. Grosser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan N. Grosser .

Editor information

Editors and Affiliations

  1. KFUPM, College of Industrial Management, Dhahran, Saudi Arabia

    Hassan Qudrat-Ullah

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Duminy, L., Grosser, S.N. (2018). Resilience as Basis for Sustainability: Shortages in Production Supply Chains for Essential Consumer Goods. In: Qudrat-Ullah, H. (eds) Innovative Solutions for Sustainable Supply Chains. Understanding Complex Systems. Springer, Cham. https://doi.org/10.1007/978-3-319-94322-0_9

Download citation

Publish with us

Policies and ethics

Search

Navigation